Renalytix shares surge 50% on unsolicited takeover approach
Shares soar almost 50% on unsolicited approachBoard hoists ?for sale? sign amid strategic reviewDiscussions to raise new equity and debtAn unsolicited takeover approach for kidney diagnostics specialist Renalytix (RENX:AIM) sent its...
04 March 2024